Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint.
Saved in:
| Title: | Ribavirin post-exposure prophylaxis for Andes virus exposure: a viewpoint. |
|---|---|
| Authors: | Brüggemann RJ; Department of Pharmacy, Pharmacology and Toxicology, and Radboudumc Community for Infectious Diseases, and Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Vollaard A; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands., de Stoppelaar S; Centre for Infectious Disease Control, National Institute for Public Health and the Environment (RIVM), Bilthoven, the Netherlands; Department of Internal Medicine, Infectious Diseases Department, Amsterdam University Medical Center, Amsterdam, the Netherlands., van Hasselt JGC; Leiden Academic Centre for Drug Research, Leiden University, Leiden, the Netherlands., Burger DM; Department of Pharmacy, Pharmacology and Toxicology, and Radboudumc Community for Infectious Diseases, and Radboudumc Institute for Medical Innovation, Radboud University Medical Center, Nijmegen, the Netherlands., Engel JJ; Department of Internal Medicine, and Radboud Institute of Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, the Netherlands., van Kampen JJA; Department of Viroscience, Erasmus MC, Rotterdam, the Netherlands., McCall M; Department of Medical Microbiology, Radboud University Medical Center, Nijmegen, the Netherlands., Smits L; Department of Internal Medicine, and Radboud Institute of Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, the Netherlands., Jolink H; Leiden University Center of Infectious Diseases, Subdepartment Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., Visser LG; Leiden University Center of Infectious Diseases, Subdepartment Infectious Diseases, Leiden University Medical Center, Leiden, the Netherlands., van de Veerdonk F; Department of Internal Medicine, and Radboud Institute of Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, the Netherlands., Veldkamp KE; Leiden University Center of Infectious Diseases, Subdepartment Medical Microbiology and Infection Control, Leiden University Medical Center, Leiden., Rovers CP; Department of Internal Medicine, and Radboud Institute of Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, the Netherlands., Arts RJW; Department of Internal Medicine, and Radboud Institute of Medical Innovation (RIMI), Radboud University Medical Center, Nijmegen, the Netherlands. Electronic address: rob.jw.arts@radboudumc.nl. |
| Source: | EBioMedicine [EBioMedicine] 2026 Jul 16; Vol. 130, pp. 106386. Date of Electronic Publication: 2026 Jul 16. |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Elsevier B.V Country of Publication: Netherlands NLM ID: 101647039 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 2352-3964 (Electronic) Linking ISSN: 23523964 NLM ISO Abbreviation: EBioMedicine Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
